Hideki Horie
Kyoto Prefectural University of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hideki Horie.
Free Radical Research | 2014
Osamu Handa; Atsushi Majima; Yuriko Onozawa; Hideki Horie; Yukiko Uehara; Akifumi Fukui; Tatsushi Omatsu; Yuji Naito; Toshikazu Yoshikawa
Abstract Non-steroidal anti-inflammatory drugs (NSAIDs) have been implemented in clinical settings for a long time for their anti-inflammatory effects. With the number of NSAID users increasing, gastroenterological physicians and researchers have worked hard to prevent and treat NSAID-induced gastric mucosal injury, an effort that has for the large part being successful. However, the struggle against NSAID-induced mucosal damage has taken on a new urgency due to the discovery of NSAID-induced small intestinal mucosal injury. Although the main mechanism by which NSAIDs induce small intestinal mucosal injury has been thought to depend on the inhibitory effect of NSAIDs on cyclooxygenase (COX) activity, recent studies have revealed the importance of mitochondria-derived reactive oxygen species (ROS) production, which occurs independently of COX-inhibition. ROS production is an especially important factor in the increase of small intestinal epithelial cell permeability, an early stage in the process of small intestinal mucosal injury. By clarifying the precise mechanism, together with its clinical features using novel endoscopy, effective strategies for preventing NSAID-induced small intestinal damage, especially targeting mitochondria-derived ROS production, may be developed.
Journal of Digestive Diseases | 2017
Atsushi Majima; Osamu Handa; Yuji Naito; Yosuke Suyama; Yuriko Onozawa; Yasuki Higashimura; Katsura Mizushima; Mayuko Morita; Yukiko Uehara; Hideki Horie; Takaya Iida; Akifumu Fukui; Osamu Dohi; Tetsuya Okayama; Naohisa Yoshida; Kazuhiro Kamada; Kazuhiro Katada; Kazuhiko Uchiyama; Takeshi Ishikawa; Tomohisa Takagi; Hideyuki Konishi; Zenta Yasukawa; Makoto Tokunaga; Tsutomu Okubo; Yoshito Itoh
In this study we aimed to verify a real‐time trans‐epithelial electrical resistance (TEER) monitoring system in a Caco‐2 monolayer and to investigate the therapeutic effect of partially hydrolyzed guar gum (PHGG), a dietary fiber, against interferon (IFN)‐γ‐induced intestinal barrier dysfunction using this monitoring system.
Gastroenterology | 2015
Atsushi Majima; Yuji Naito; Osamu Handa; Yuriko Onozawa; Yukiko Uehara; Hideki Horie; Mayuko Morita; Yasuki Higashimura; Katsura Mizushima; Tetsuya Okayama; Kazuhiro Katada; Kazuhiro Kamada; Kazuhiko Uchiyama; Ishikawa Takeshi; Tomohisa Takagi; Yoshito Itoh; Zenta Yasukawa; Makoto Tokunaga; Tsutomu Okubo
Protective Effects of Partially Hydrolyzed Guar Gum Against Intestinal Epithelial Barrier Dysfunction Atsushi Majima, Yuji Naito, Osamu Handa, Yuriko Onozawa, Yukiko Uehara, Hideki Horie, Mayuko Morita, Yasuki Higashimura, Katsura Mizushima, Tetsuya Okayama, Kazuhiro Katada, Kazuhiro Kamada, Kazuhiko Uchiyama, Ishikawa Takeshi, Tomohisa Takagi, Yoshito Itoh, Zenta Yasukawa, Makoto Tokunaga, Tsutomu Okubo
Gastroenterology | 2015
Yuriko Onozawa; Yuji Naito; Osamu Handa; Atsushi Majima; Kentaro Suzuki; Yukiko Uehara; Hideki Horie; Ying Qin; Mayuko Morita; Yasuki Higashimura; Katsura Mizushima; Osamu Dohi; Tetsuya Okayama; Naohisa Yoshida; Kazuhiro Kamada; Kazuhiro Katada; Kazuhiko Uchiyama; Takeshi Ishikawa; Tomohisa Takagi; Hideyuki Konishi; Yoshito Itoh
Aims: The alarmin HMGB1 is released during cell damage and acts as an early or late stage inflammatory cytokine at multiple levels of target cells. The Na+/H+ exchanger Isoform 3 (NHE3) is the major intestinal salt and fluid absorptive transporter and its function is defective in intestinal inflammation. Aim of the study: We wanted to know if HMGB1 can affect NHE3 mRNA or protein expression as well as its localization in mucosal tissue form patients with ulcerative colitis and in NHE3-expressing Caco2bbe colonic cells. Methods and Results: We studied the mRNA and protein expression and localization of HMGB1 and NHE3 in rectal biopsies from the inflamed and noninflamed mucosa of patients with ulcerative colitis by quantitative qPCR and immunohistochemistry. TNF-α and IFN-γmRNA level was significantly elevated in lesions compared to that in its adjacent normal tissue samples of UC patients rectal, suggesting a reliable endoscopic sampling of inflamed vs noninflamed tissue. HMGB1 mRNA and protein expression was increased in the inflamed as compared to adjacent normal tissues, and it was mostly distributed in cytoplasm and extracellular region. NHE3 protein was markedly reduced in inflamed compared to adjacent normal tissues, though its mRNA level was not significantly different between inflamed and noninflamed mucosa. When Caco2bbe cells overexpressing human NHE3 (Caco2bbe/ hNHE3) were incubated with high concentration of rh-HMGB1 (10μg/ml), NHE3 mRNA was found to be decreased at 1h (0.385±0.015 vs. 1.011±0.011, p 0.05). NHE3 protein, measured byWestern analysis, was not significantly changed when co-cultured with 10μg/ml rhHMGB1 for 1h or 6h, however, it was dramatically decreased at 24h of co-culture with 10μg/ml rhHMGB1. IFN-gamma levels were markedly increased when Caco2bbe/hNHE3 cells were incubated with 10 μg/ml rhHMGB1 for 1h as compared with normal group (29.855±0.055 vs. 29.525±0.050, p 0.05) and 24h (29.066±0.181 vs. 29.525±0.050, p>0.05) of co-culture with 10μg/ml rhHMGB1 as compared to normal group. This suggests that incubation with rhHMGB1 may down-regulate NHE3 mRNA expression via elevated IFN-gamma level at early stage (1h), resulting in a decrease in NHE3 protein expression at late stage (24h). Conclusion: Decreased NHE3 protein level was accompanied by elevated cytoplasm and extracellular HMGB1 in human ulcerative rectitis tissue. This may result from the regulatory effect of cytokines such as IFNgamma induced by exogenous HMGB1 at late stage of inflammation.
Gastroenterology | 2013
Takaya Iida; Yuji Naito; Tomohisa Takagi; Kazuhiro Katada; Katsura Mizushima; Yasuki Higashimura; Syunsuke Kishimoto; Kentaro Suzuki; Hideki Horie; Wataru Fukuda; Yutaka Inada; Yukiko Uehara; Munehiro Kugai; Hiroyuki Yoriki; Toshifumi Tsuji; Akifumi Fukui; Kazuhiro Kamada; Kazuhiko Uchiyama; Osamu Handa; Nobuaki Yagi; Toshikazu Yoshikawa
Rapamycin Reduced the Mortality in Mice Injured by Intestinal IschemiaReperfusion Through the Inhibition of Remote Organ Failure Takaya Iida, Yuji Naito, Tomohisa Takagi, Kazuhiro Katada, Katsura Mizushima, Yasuki Higashimura, Syunsuke Kishimoto, Kentaro Suzuki, Hideki Horie, Wataru Fukuda, Yutaka Inada, Yukiko Uehara, Munehiro Kugai, Hiroyuki Yoriki, Toshifumi Tsuji, Akifumi Fukui, Kazuhiro Kamada, Kazuhiko Uchiyama, Osamu Handa, Nobuaki Yagi, Toshikazu Yoshikawa
Gastroenterology | 2013
Kentaro Suzuki; Yuji Naito; Kazuhiro Kamada; Syunsuke Kishimoto; Yukiko Uehara; Hideki Horie; Wataru Fukuda; Yutaka Inada; Takaya Iida; Munehiro Kugai; Toshifumi Tsuji; Hiroyuki Yoriki; Akifumi Fukui; Yasuki Higashimura; Katsura Mizushima; Kazuhiro Katada; Kazuhiko Uchiyama; Osamu Handa; Tomohisa Takagi; Nobuaki Yagi; Zenta Yasukawa; Makoto Tokunaga; Tsutomu Okubo; Lekh Raj Juneja; Toshikazu Yoshikawa
Partially Hydrolyzed Guar Gum (PHGG) Inhibits Castor Oil-Induced Diarrhea in Rats Through the Inhibition of Substance P Production Kentaro Suzuki, Yuji Naito, Kazuhiro Kamada, Syunsuke Kishimoto, Yukiko Uehara, Hideki Horie, Wataru Fukuda, Yutaka Inada, Takaya Iida, Munehiro Kugai, Toshifumi Tsuji, Hiroyuki Yoriki, Akifumi Fukui, Yasuki Higashimura, Katsura Mizushima, Kazuhiro Katada, Kazuhiko Uchiyama, Osamu Handa, Tomohisa Takagi, Nobuaki Yagi, Zenta Yasukawa, Makoto Tokunaga, Tsutomu Okubo, Lekh R. Juneja, Toshikazu Yoshikawa
Gastroenterology | 2013
Munehiro Kugai; Kazuhiko Uchiyama; Kentaro Suzuki; Yukiko Uehara; Hideki Horie; Yutaka Inada; Wataru Fukuda; Takaya Iida; Toshifumi Tsuji; Hiroyuki Yoriki; Akifumi Fukui; Naohisa Yoshida; Kazuhiro Katada; Kazuhiro Kamada; Tomohisa Takagi; Osamu Handa; Hideyuki Konishi; Nobuaki Yagi; Yuji Naito
Introduction Intestinal fibrosis (IF) is a major complication of chronic inflammation of the intestinal tissue in inflammatory bowel disease (IBD). IF can cause narrowing of the intestinal lumen, which may lead to stricture formation. Currently, adequate models are lacking to study the mechanism of intestinal fibrosis in IBD. Our aim is to develop an ex vivo model for IF by using mouse precision-cut intestinal slice (PCIS). In addition, regional differences in the onset of fibrosis in the bowel will be studied. In PCIS all cell types are present in their original tissue-matrix environment. As fibrosis is a multicellular phenomenon, PCIS can be used as a model to study the early onset of intestinal fibrosis. Methods Mouse jejunum, ileum and colon were excised and prepared as segments embedded in agarose. PCIS (estimated 300-400 μm) were prepared and incubated up to 48 hr. ATP content of the PCIS was used to assess the general viability. To study the early onset of fibrosis, the gene expression of different fibrosis markers: Pro-Collagen 1 A1 (COL1A1), Heat Shock Protein 47 (HSP47), alpha-Smooth Muscle Actin (SMA) and Fibronectin (FN1) was determined in PCIS after 48 hr of incubation. Results Mouse PCIS from the different regions of the bowel were viable up to 48 hr in culture. After 48 hr of incubation of PCIS, HSP47 and FN1 gene expression was significantly up-regulated, compared to PCIS directly after slicing, in jejunum (3.9 and 3.6 fold, respectively) and in ileum (4.5 and 4.9 fold, respectively). Gene expression of Col1A1 (0.7 fold) was only down-regulated in PCIS from the colon. SMA gene expression was down-regulated in PCIS from all the regions of the intestine. PCIS from jejunum cultured in the presence of 5ng/mL Transforming-Growth Factor (TGF)β1 for 48 hr, HSP47 (1.2 fold), FN1 (4.6 fold) and COL1A1 (2.0 fold) were significantly upregulated compared to control PCIS after 48 hr of incubation. In addition, in PCIS from Ileum incubated with 5ng/mL TGF-β1, the gene expression of HSP47 (1.9 fold) and FN1 (3.9 fold) was significantly increased. In PCIS from the colon cultured for 48 hr in the presence of 5ng/ml TGF-β1, the gene expression of fibrosis markers was not affected. Conclusion Mouse PCIS from different regions of the bowel can successfully be cultured for 48 hr. Fibrosis markers are induced by incubation up to 48 hr and by addition of TGFβ1 in jejunum and ileum PCIS, but not in colon PCIS. We are the first to show that regional differences in the onset of intestinal fibrosis can be measured using PCIS.
Molecular Medicine Reports | 2017
Yuriko Onozawa; Osamu Handa; Yuji Naito; Chihiro Ushiroda; Yosuke Suyama; Yuki Toyokawa; Takaaki Murakami; Tomoyo Yasuda; Tomohiro Ueda; Atsushi Majima; Yuma Hotta; Toshifumi Doi; Makoto Tanaka; Yusuke Horii; Yasuki Higashimura; Katsura Mizushima; Mayuko Morita; Yukiko Uehara; Hideki Horie; Akifumi Fukui; Osamu Dohi; Tetsuya Okayama; Naohisa Yoshida; Kazuhiro Kamada; Kazuhiro Katada; Kazuhiko Uchiyama; Takeshi Ishikawa; Tomohisa Takagi; Hideyuki Konishi; Yoshito Itoh
Gastrointestinal Endoscopy | 2013
Osamu Handa; Yuji Naito; Yuriko Onozawa; Tomoko Kitaichi; Yusuke Horii; Kentaro Suzuki; Hideki Horie; Yukiko Uehara; Wataru Fukuda; Yutaka Inada; Takaya Iida; Akifumi Fukui; Naohisa Yoshida; Tetsuya Okayama; Kazuhiro Kamada; Kazuhiro Katada; Kazuhiko Uchiyama; Takeshi Ishikawa; Tomohisa Takagi; Hiroaki Yasuda; Junichi Sakagami; Hideyuki Konishi; Nobuaki Yagi; Satoshi Kokura; Toshikazu Yoshikawa
Gastroenterology | 2015
Yusuke Horii; Kazuhiko Uchiyama; Yuma Hotta; Atsushi Majima; Toshifumi Doi; Makoto Tanaka; Yuriko Onozawa; Kentaro Suzuki; Yukiko Uehara; Hideki Horie; Osamu Dohi; Tetsuya Okayama; Naohisa Yoshida; Kazuhiro Katada; Kazuhiro Kamada; Takeshi Ishikawa; Osamu Handa; Tomohisa Takagi; Hideyuki Konishi; Yuji Naito; Akihiko Muto; Kazuhiko Igarashi; Yoshito Itoh